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Abstract
Introduction: The cancer patients are at a high risk of developing perioperative 
complications. Cardiopulmonary exercise testing (CPET) is a non-invasive, 
perioperative risk stratification tool that predicts perioperative morbidity 
and mortality. Prior literature has concluded that CPET has a valuable role 
in predicting post-operative complications in major surgical procedures. 
However, the data on the effectiveness of CPET in evaluating the perioperative 
risk in cancer-specific populations are limited. This study assessed the 
usefulness of CPET in perioperative risk stratification of patients with 
thoracoabdominal cancer who underwent elective major thoracoabdominal 
surgeries. Materials and Methods: A retrospective observational cohort 
study was conducted on cancer patients that underwent pre-operative CPET 
at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, 
Pakistan, from September 2017 to September 2019. All adult male and female 
patients with a significant medical history for cancer of the thoracoabdominal 
region who underwent CPET before a major thoracoabdominal surgery were 
included in the study. Results: A total of 32 patients were included in the 
present investigation. The mean age of the sample was 62.75 ± 10.18 years, 
and the majority of the participants were female. Following surgery, 53% of 
the participants had post-operative complications in terms of morbidity and 
mortality. Fifteen participants had an anaerobic threshold (AT) of ≥11.0 ml/
kg/min. Among these, 12 participants had an uneventful surgery. On the 
contrary, among 17 participants that were considered to have a high risk 
(<11.0 ml/kg/min) for surgery, 14 subjects (82%) had at least one complication 
(including mortality). The sensitivity and specificity of CPET to anticipate 
complications during oncological surgery were calculated to be 82% and 
80%, respectively. The mean AT of participants with uneventful surgery was 
calculated to be 11.83 ± 1.01 ml/kg/min. This was statistically greater than the 
AT of subjects that had morbidity (9.86 ± 1.20 ml/kg/min) or mortality (8.95 ± 
0.35 ml/kg/min) (P < 0.001). Conclusion: CPET, when using AT alone as an 
indicator, can provide a good-excellent prediction of perioperative outcome 
among oncology patients undergoing major thoracoabdominal surgical 
procedures.
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Introduction
Cancer is the leading cause of morbidity and 
mortality worldwide as per the World Health 
Organization, with approximately 14 million new 
cases and 8.2 million cancer-related death every 
year.[1] The cancer patients are at high risk for 
developing perioperative complications secondary 
to cancer disease itself and from other risk factors 
such as chemotherapy, radiation therapy or 
corticosteroids and malnourishment.[2,3] These risk 
factors render the pre-operative prediction of risk 
assessment of cancer patients convoluted.
Numerous risk stratification tools have been 
formulated to supplement the traditional clinical 
judgment for perioperative complications. 
These include various risk scoring systems 
(American Society of Anesthesiologists physical 
status classification, Child-Pugh classification 
and modified end-stage liver disease criteria), 
biomarkers (troponin, C-reactive protein and B-type 
natriuretic peptide) and subjective assessment 
test for determining the functional status of the 
patient (metabolic equivalents [METS], shuttle walk 
talk test and 6-min walk test).[4-9] However, these 
risk stratification tools have limited value in the 
management of complex oncological patients.[2,3]
Cardiopulmonary exercise testing (CPET) is a non-
invasive, perioperative risk stratification tool, which 
has two main variables, anaerobic threshold (AT) 
and the maximum oxygen capacity (Vo2max), which 
are used to predict perioperative morbidity and 
mortality.[10,11] AT is when anaerobic metabolism 
(lactic acidosis) starts in the muscles during 
graded exercise due to an imbalance between 
oxygen demand and supply. The patient begins 
to compensate for this physiological phenomenon 
through an increase in exhaled carbon dioxide 
(Vco2). The Vo2max is a maximum physiological 
endpoint; it is defined as the maximum capacity 
of an individual body to transport and use oxygen 
during incremental exercise.
Prior literature has concluded that CPET has 
a valuable role in predicting post-operative 
complications in cardiothoracic, liver, pancreatic 
and other abdominal surgeries.[12] Nonetheless, 
there are limited data on the effectiveness of CPET 
for evaluating the perioperative risk for surgeries 
on the cancer-specific population. Moreover, as 
per the authors’ understanding, assessment of the 
usefulness of CPET in predicting perioperative risk 
has not been studied in the local community.
The purpose of this study was to assess the 
usefulness of CPET in perioperative risk stratification 
of patients with thoracoabdominal cancer that 
underwent elective major thoracoabdominal 
surgeries. 
Materials and Methods
Study design and clinical settings
A retrospective observational cohort study was 
conducted on cancer patients that underwent 
pre-operative CPET at Shaukat Khanum Memorial 
Cancer Hospital and Research Centre, Lahore, 
Pakistan, from September 2017 to September 
2019. An approval from the Institutional Review 
Board was obtained (EXMPT-04-10-18-03).
Clinical information
All adult male and female participants with a 
significant medical history for cancer of the 
thoracoabdominal region which underwent 
CPET before a major thoracoabdominal surgery 
were included in the present investigation. In this 
study, we defined major surgery as a procedure 
requiring general anaesthesia, and during which 
the mesenchymal barrier was breached, an organ 
was partially or entirely removed, the anatomy was 
altered, and the participant required an overnight 
stay in the hospital. Subjects who were unable to 
complete the test, had an active cardiac condition 
as per the American Heart Association, or were 
pregnant were excluded from the study.[12]
The Hospital Information System (HIS) was used 
to retrieve and deidentify medical records of the 
subjects. Information regarding demographic data, 
diagnosis, type of surgery, revised cardiac index, 
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METS, body mass index (BMI), comorbidity status 
and the AT was reviewed. Similarly, details of the 
length of stay (LOS) in the intensive care unit (ICU) or 
high dependency unit, length of hospital stay, delay 
or complications during surgery, post-operative 
complications and the number of mortality days 
were extracted from the medical record. Post-
operative complications were observed using the 
post-operative morbidity survey tool.[13]
CPET protocol
During the CPET, all participants underwent 
symptom-l imited incremental  testing on 
a computer-controlled electromagnetically 
braked cycle ergometer under a respiratory 
therapist’s supervision. In the beginning, each 
participant was given 3 min of preliminary resting 
period on a cycle ergometer. Their baseline 
measurements (such as heart rate, blood pressure 
and oxygen consumption [VO2]) were established. 
This was followed by a 3-min warm-up period, 
which consisted of participant pedaling on an 
unloaded cycle ergometer at 0 Watts resistance. 
Subsequently, pedaling resistance was increased 
using an incremental ramp protocol at 10 Watts/
min for untrained participants and 20–30 Watts/
min for trained participants or those with a history 
of regular physical exercise. All the measurements 
were recorded continuously throughout the test. 
Participants underwent breath by breath analysis 
of VO2 (till peak VO2 was reached), carbon dioxide 
production, arterial oxygen tension and rating of 
perceived exertion (based on Modified Borg Scale). 
The peak VO2 and the AT were determined by the 
physician using graphical and numeric findings 
of the test. The test was terminated if the patients 
started to develop chest pain or extreme shortness 
of breath and could not follow the protocol due 
to tiredness. This was in compliance with testing 
guidelines and is indicated due to participant 
safety.
AT was used for the risk stratification of the 
participants in the present investigation. Participants 
with AT of ≥11.0 ml/kg/min were classified as 
having a low risk for surgery, and correspondingly 
participants with AT of <11.0 ml/kg/min were 
categorised as having a high risk for surgery. 
Cutoff of 11.0 ml/kg/min was selected because it 
has previously been used by other investigators 
studying the role of AT in stratifying risk of surgical 
outcomes.[14,15]
Statistical analysis
The statistical analysis was carried out using SPSS 
software (version 20.0; SPSS, Chicago, IL, USA). 
Continuous variables were compounded as mean 
(± standard deviation), and categorical variables 
were computed as frequencies and percentages. 
The continuous variables were compared using a 
one-way analysis of variance (ANOVA) test. Overall 
determination for AT value was evaluated by repeated 
measurement ANOVA. Furthermore, regression 
analyses were performed by standard methods to 
calculate the correlation coefficient. Differences were 
considered to be significant at P < 0.05. 
Results
A total of 75 charts were identified and reviewed. 
However, 32 participants met the inclusion and 
exclusion criteria of the study and underwent 
an oncological surgery. On the contrary, 43 
participants were excluded for at least one of 
the following reasons; participants were unable 
to complete the test due to either exertional 
dyspnoea, chest pain, palpitations or arthritis,[4] or 
subjects did not proceed for surgery due to either 
disease progression, and the tumour was deemed 
irresectable by the oncological surgeon, or they 
were considered to have a high risk for surgery as 
per low AT <9.32 ml/kg/min (3).
The mean age of the sample was 62.75 ± 10.18 
years, and the majority of the participants were 
female, 65% (n = 21). The mean BMI of the subjects 
was 33.12 ± 5.40 kg/m2. In addition, 75% (n = 24) 
of participants had multiple comorbidities, such 
as ischemic heart disease, diabetes mellitus, 
hypertension, asthma and chronic obstructive 
pulmonary disorder. The metabolic equivalent was 
above 4 in 84.4% (n = 27) of participants [Table 1].
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The most common surgical procedures performed 
following CPET were in the upper gastrointestinal 
region [Figure  1]. Around 53% (n = 17) of the 
participants had post-operative complications 
in terms of morbidity and mortality. The most 
common complications were associated with the 
cardiovascular system 35.4% (n = 6), which consisted 
of arrhythmias and drop in mean arterial pressure 
of <65 mmHg (requiring inotropic support), and 
respiratory system 23.5% (n = 4) which included 
of an increase in oxygen requirement during 
surgery and respiratory acidosis. Following surgery, 
6.3% (n = 2) of the participants had mortality. These 
results are summarised in Table 2.
Fifteen participants had AT of ≥11.0 ml/kg/min. 
Among these, 80% (n = 12) had an uneventful 
surgery. On the contrary, among 17 participants 
considered to have a high risk for surgery, 82% 
(n = 14) had at least one complication (including 
mortality). The sensitivity and specificity of CPET to 
anticipate complications during oncological surgery 
were calculated to be 82% and 80%, respectively.
The mean AT of subjects with uneventful surgery 
was 11.83 ± 1.01 ml/kg/min. This was statistically 
greater than the AT of participants that had 
morbidity (9.86 ± 1.20 ml/kg/min) or mortality (8.95 
± 0.35 ml/kg/min) (P < 0.001).
Table 2: Breakdown of the study population according to the anaerobic threshold
Study variables Categories High risk (AT value <11.0 ml/kg/min) Low risk (AT value ≥11.0 ml/kg/min) P-value
Age (years) 61.35±9.94 64.33±10.58 0.42
Gender Male 6 (35.3%) 5 (33.3%) 0.91
Female 11 (64.7%) 10 (66.7%)
Body mass index (kg/m2) 32.65±4.85 33.67±6.10 0.60
Comorbidity 
status
Single 4 (23.5%) 4 (26.7%) 1.00
Multiple 13 (76.5%) 11 (73.3%)
Post-operative 
complications
Absent 3 (17.6%) 12 (80.0%) 0.001
Present 14 (82.4%) 3 (20.0%)
Metabolic equiv-
alent 
≤4 14 (82.4%) 13 (13.3%) 1.00
>4 3 (17.6%) 2 (86.7%)
Hospital stay (days) 6.17±0.81 6.0±0.75 0.53






Gender Male 11 (34.4%)
Female 21 (65.6%)
Body mass index (kg/m2) 33.12±5.40
Comorbidity status Single 8 (25.0%)
Multiple 24 (75.0%)
Post-operative complications 17 (53.1%)
Metabolic equivalent ≤4 27 (84.4)
>4 5 (15.6)
Hospital stay (days) 6.10±0.78
Intensive care unit stay (days) 1.52±0.72
Anaerobic threshold (ml/kg/min) 10.73±1.50
n = 14 (43%)
n = 10 (31%)










Esophagectomy Whipple Colorectal Gastrectomy
Figure  1: Procedure-wise breakdown of patients 
undergoing cardiopulmonary exercise testing
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There was a statistically significant difference 
present between the group of participants with AT 
value of <11.0 ml/kg/min and those with AT value 
of ≥11.0 ml/kg/min (P < 0.001). On the contrary, 
there was no statistically significant difference 
between age, gender, BMI comorbidity status, 
METS, length of hospital stay and duration of stay 
in the ICU [Table 2]. 
Discussion
This study assessed the usefulness of CPET in 
perioperative risk stratification of patients with 
thoracoabdominal cancer who underwent elective 
major oncological surgeries. Among 32 subjects 
included in the present investigation, 15 subjects 
were categorised as having a minimal risk (AT of 
≥11.0 ml/kg/min) and 17 subjects were classified 
as having a high risk (AT of <11.0 ml/kg/min) 
for post-operative complications. The sensitivity 
of the CPET to predict complications during 
oncological surgery was calculated to be 82% 
and the specificity of the test was analysed to be 
80%. Correspondingly, subjects with uneventful 
surgery had significantly higher AT than those with 
morbidity or mortality. 
In the present study, AT was used as a single 
variable for CPET analysis, and the optimal cutoff 
value of AT of 11.0 ml/kg/min was used. Prior 
investigators have suggested the threshold of 
11.0 ml/kg/min.[14,15] Older et al. conducted a 
study on 548 elderly patients undergoing major 
intra-abdominal surgery. The investigators showed 
that a pre-operative AT value of <11.0 ml/kg/min 
was associated with increased cardiovascular 
mortality.[14] Similarly, in a study on 106 patients 
undergoing elective gastric bypass surgery, Swart 
et al. reported a higher number of post-surgical 
complications in low AT group.[15]
In the present investigation, low AT value was 
associated with morbidity and mortality. These 
findings are similar to those reported by others.[14-17] 
CPET measures uptake of oxygen at increasing 
levels of physical work, and the test objectively 
determines the cardiopulmonary performance 
under conditions of stress (such as during surgery). 
Under exercise conditions, oxygen consumption 
becomes a linear function of cardiac output, and 
the measurement of aerobic capacity becomes a 
surrogate for the estimation of ventricular function. 
AT is the point at which aerobic metabolism is 
inadequate for maintaining high-energy phosphate 
production in the exercising muscles, thus forcing 
the anaerobic metabolism to make up the deficit. 
Anaerobic metabolism occurs in any tissue where 
oxygen delivery is inadequate to meet the energy 
requirement. This phenomenon has led to the 
concepts of ‘surgical AT’ and ‘post-operative organ 
complications,’ the heart’s inability to meet the 
demand of post-operative stress.[18,19]
In the present investigation, the sensitivity and 
specificity of CPET were calculated to be 82% and 
80%, respectively. These findings are different 
from those reported by other investigators. A 
reason for this disparity is likely to be associated 
with a difference in the optimal cut-point threshold 
that was used for the analyses. Furthermore, the 
cohorts on whom the investigations have been 
conducted are different. Snowden et al. reported 
a higher sensitivity (88%) and a similar specificity 
(79%) compared to the present study of CPET 
in predicting complications among patients 
undergoing major elective surgery. However, they 
used a relatively lower optimal cutoff point of AT 
value (10.1 ml/kg/min).[16] Similarly, Junejo et al. 
assessed CPET performance in risk stratification 
of patients undergoing hepatic resection. The 
investigators concluded that CPET had a sensitivity 
of 100% and a specificity of 76% in predicting 
complications during surgery using a cutoff value 
of AT of 9.9 ml/kg/min.[20]
Studies have reported that low AT may also increase 
unplanned stay in ICU. [20-23] Previously, Hennis et al. 
reported that patients with AT of more than 11.3 
ml/kg/min had fewer than 3 days, whereas patients 
with AT of <10.4 ml/kg/min had a LOS of more than 
3 days.[24] Comparing our results with Hennis et al., 
average LOS in the hospital was approximately 
6 days and 1.5 days in ICU. This LOS was not a 
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significant correlation between the extent of stay 
in the hospital/ICU and AT. The reason for this 
discrepancy in results is likely due to the difference 
in the study population. In the present study, all 
patients had thoracoabdominal carcinomas, and 
they underwent major elective surgical procedures 
with curative intent. Similarly, in the hospital where 
the investigation was conducted, it was a standard 
operating procedure of the surgical oncology to 
have patients stay in the hospital for an extended 
period (5–7 days) postoperatively following a major 
thoracoabdominal procedure. 
A possible limitation of this study is that only AT was 
used for risk stratification of the subjects before the 
intervention. The authors were not able to include 
Vo2max due to the unavailability of CPET software. 
Nonetheless, the findings of the present study are 
corresponding to the investigations that have relied 
on both AT and Vo2max for stratifying risk among 
patients undergoing major surgeries. Another 
limitation of the study is the retrospective design. 
Retrospective studies are traditionally considered 
low quality in the hierarchy of evidence due to lack 
of randomisation. Due to their inherent design, they 
have the potential for forming false associations or 
magnifying positive responses. Nonetheless, in the 
present study, all participants’ data were reviewed 
using the electronic HIS, and clinical findings 
(morbidity or mortality) from follow-up visits were 
cross-checked from visits of participants to different 
specialties. 
To conclude CPET, when using AT alone, 
can provide a good-excellent prediction of 
perioperative outcomes among oncology patients 
undergoing major thoracoabdominal surgical 
procedures. Future investigations with prospective 
study design and large sample sizes are advocated 
for improving understanding and utilisation of 
CPET in stratifying perioperative risk among cancer 
patients undergoing major surgical procedures.
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